Weight regain after stopping GLP-1 therapy affects up to 70% of patients within one year. PlexusDx offers continuous, affordable semaglutide therapy to help you sustain results long-term without interruption.

Constipation affects up to 25% of semaglutide users during the first month of treatment. PlexusDx explains safe laxative options, lifestyle adjustments, and when to seek medical guidance for GLP-1 digestive side effects.

Semaglutide is administered once weekly via injection, starting at low doses and gradually increasing over 16 weeks to minimize side effects and maximize weight loss results.

Weight loss plateaus on semaglutide are common after 3–6 months of steady progress. PlexusDx explains the science behind GLP-1 tolerance and offers genetic testing to describe the pathway-level variants involved.

Wegovy is available as a once-weekly injection, but oral semaglutide tablets offer an alternative for patients who prefer not to self-inject. PlexusDx provides both forms, allowing you to choose what fits your lifestyle.

Semaglutide injections are administered once weekly, starting at a low dose and gradually increasing over 16 weeks to minimize side effects while maximizing weight loss results.

GLP-1 injections like semaglutide are designed for comfort, and most patients experience minimal to no pain during weekly administration. PlexusDx breaks down what to expect and how to make your weight loss journey as comfortable as possible.

Semaglutide is a GLP-1 receptor agonist that helps regulate appetite and blood sugar, making it a practical option for sustainable weight loss when combined with lifestyle changes.

Wegovy uses a step-wise dosing schedule that increases over 16 weeks, but your actual maintenance dose depends on tolerance and goals. PlexusDx semaglutide maintains one flat monthly price as your dose adjusts upward.

Taking your semaglutide injection early can disrupt your body's rhythm and medication effectiveness. PlexusDx explains the importance of consistent weekly timing and what to do if you need schedule flexibility.

Sulfur burps are a frequent side effect reported by people taking semaglutide for weight loss. Understanding what causes them and how to manage them can help you stay comfortable during your treatment journey.

Wegovy begins at 0.25 mg weekly and increases over 16 weeks to reach maintenance doses. PlexusDx offers compounded semaglutide at $189/mo month-to-month, or from $149/mo on the 6-month plan—a more accessible path to GLP-1 therapy without dose-based pricing.

Nausea affects up to 40% of GLP-1 users in clinical trials, but several proven strategies can minimize this side effect. PlexusDx explains how to manage nausea safely while continuing your weight loss therapy.

Starting semaglutide at 0.25 mg marks the beginning of your personalized weight loss journey. This guide walks you through proper injection technique, storage requirements, and realistic expectations for your first week of therapy.

Many people experience weight loss plateaus after initial success with semaglutide. Understanding why this happens and exploring personalized treatment adjustments can help you break through and continue progressing toward your goals.

Both Zepbound and Wegovy are FDA-approved GLP-1 medications, but they work through different mechanisms. Learn which may suit your weight loss goals and how compounded versions offer the same active ingredients at lower cost.

Nausea and vomiting are common in the first weeks of Wegovy treatment, affecting up to 25% of users. Understanding the cause, timeline, and management strategies helps you stay on track with your weight loss goals.

Most patients need 4 to 12 weeks to fully adjust to semaglutide, though initial side effects typically peak within the first two weeks and gradually improve as your body adapts to the medication.

Wegovy's maximum dose reaches 2.4 mg weekly, but optimal therapy depends on individual genetics and metabolic response. PlexusDx uses precision genetic testing to match you with the right medication and dosing strategy for sustainable weight loss.

Semaglutide timing can influence appetite suppression and medication tolerability, though the weekly injection format offers flexibility that daily medications lack. Discover how to optimize your injection schedule for your weight loss goals.

Many patients report not physically feeling their semaglutide injection during administration. This is completely normal. PlexusDx explains why subcutaneous GLP-1 injections often produce no sensation and when to contact your provider.

Semaglutide users typically lose between 1–2 pounds per week during the first month, with total losses ranging from 4–8 pounds depending on starting weight, diet, and exercise habits. PlexusDx personalizes your therapy to optimize outcomes.

Semaglutide works best when paired with intentional food choices that reduce appetite and stabilize blood sugar. PlexusDx explains which nutrients support lasting weight loss and how to eat for success on GLP-1 therapy.

Starting GLP-1 therapy at the lowest dose raises real questions about effectiveness. PlexusDx breaks down the clinical evidence and shows how microdosing strategies can deliver results when paired with genetic insight and careful monitoring.

Wegovy and Ozempic both contain semaglutide, but they're marketed differently and priced distinctly. PlexusDx offers compounded semaglutide injection at $189/mo month-to-month, or from $149/mo on the 6-month plan, delivering the same active ingredient without brand markup.

Semaglutide typically shows measurable weight loss effects within 4 to 12 weeks of starting treatment, though individual timelines vary based on metabolism, adherence, and genetic factors. PlexusDx helps personalize your expectations.

Most people begin noticing appetite suppression within days of starting semaglutide, but measurable weight loss typically appears within 2–4 weeks. PlexusDx offers affordable compounded semaglutide injections at $189/mo month-to-month, or from $149/mo on the 6-month plan to help you achieve sustainable results.

Wegovy clinical trials show average weight loss of 15–22% of body weight over 68 weeks. Individual results vary based on genetics, lifestyle, and dosing strategy. PlexusDx offers compounded semaglutide at $189/mo month-to-month, or from $149/mo on the 6-month plan to help you achieve sustainable weight reduction.

Semaglutide activates GLP-1 receptors in your brain to reduce hunger and slow stomach emptying, making weight loss more sustainable. PlexusDx offers compounded semaglutide injections at $189/mo month-to-month, or from $149/mo on the 6-month plan with personalized genetic guidance.

Semaglutide's cholesterol-lowering effects extend beyond weight loss. Clinical evidence shows meaningful improvements in lipid profiles, particularly LDL cholesterol and triglycerides, making it a dual-benefit therapy for metabolic health.